FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945956893> ?p ?o ?g. }

• W2945956893 endingPage "131" @default.
• W2945956893 startingPage "126" @default.
• W2945956893 abstract "Objective To determine how often prostate- and bladder-specific medications for lower urinary tract symptoms are used following a transurethral prostatectomy (TURP). Methods This study utilized several linked, routinely collected datasets from the province of Ontario, Canada to identify men older than 66 years who underwent their first TURP between April 2003 and March 2016. The primary outcome was the probability of using at least 30 days of either prostate-specific alpha blockers (AB), 5-alpha reductase inhibitors (5ARI), or anticholinergics/beta-3 agonists (AC/B3) after their TURP. Results We identified 58,038 men (median age 75), with a median follow-up of 4.9 years. In the 6 months prior to their TURP, AB, 5ARIs or AC/B3 were used by 62%, 32%, and 6%, respectively. Following a 90-day washout period after TURP, these medications were used by 27%, 20%, and 15% of men, respectively. The cumulative probability of using these medications within the first 10 years after TURP was 38%, 28%, and 20%, respectively. Family physicians prescribed the majority of AB, while urologists prescribed the majority of the AC/B3. Among men on AC/B3 prior to TURP, 46% used them after TURP; in multivariate cox regression analysis age ≥75, diabetes, preoperative use of AC/B3, and no preoperative urinary retention predicted postoperative utilization of AC/B3 medications. Conclusion There is considerable use of AB and 5ARIs despite a lack of evidence for using these medications after a TURP. Given the well-characterized placebo response in BPH patients, this practice should be properly evaluated for clinical efficacy." @default.
• W2945956893 created "2019-05-29" @default.
• W2945956893 creator A5006747908 @default.
• W2945956893 creator A5068976678 @default.
• W2945956893 creator A5074081266 @default.
• W2945956893 creator A5080448752 @default.
• W2945956893 date "2019-08-01" @default.
• W2945956893 modified "2023-10-11" @default.
• W2945956893 title "The Utilization of Benign Prostatic Hyperplasia and Bladder-Related Medications After a Transurethral Prostatectomy" @default.
• W2945956893 cites W101374796 @default.
• W2945956893 cites W1849315941 @default.
• W2945956893 cites W1945259997 @default.
• W2945956893 cites W1970053894 @default.
• W2945956893 cites W1973357685 @default.
• W2945956893 cites W1999393802 @default.
• W2945956893 cites W2005687876 @default.
• W2945956893 cites W2018142772 @default.
• W2945956893 cites W2038922251 @default.
• W2945956893 cites W2056030667 @default.
• W2945956893 cites W2065669941 @default.
• W2945956893 cites W2078197568 @default.
• W2945956893 cites W2081597080 @default.
• W2945956893 cites W2112004760 @default.
• W2945956893 cites W2113137108 @default.
• W2945956893 cites W2121759271 @default.
• W2945956893 cites W2132144530 @default.
• W2945956893 cites W2148631967 @default.
• W2945956893 cites W2159379731 @default.
• W2945956893 cites W2483800985 @default.
• W2945956893 cites W2522292845 @default.
• W2945956893 cites W2560940545 @default.
• W2945956893 cites W2573491891 @default.
• W2945956893 cites W2588841781 @default.
• W2945956893 cites W2791742253 @default.
• W2945956893 cites W2804551733 @default.
• W2945956893 cites W2888514343 @default.
• W2945956893 doi "https://doi.org/10.1016/j.urology.2019.05.003" @default.
• W2945956893 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31129193" @default.
• W2945956893 hasPublicationYear "2019" @default.
• W2945956893 type Work @default.
• W2945956893 sameAs 2945956893 @default.
• W2945956893 citedByCount "13" @default.
• W2945956893 countsByYear W29459568932019 @default.
• W2945956893 countsByYear W29459568932021 @default.
• W2945956893 countsByYear W29459568932022 @default.
• W2945956893 countsByYear W29459568932023 @default.
• W2945956893 crossrefType "journal-article" @default.
• W2945956893 hasAuthorship W2945956893A5006747908 @default.
• W2945956893 hasAuthorship W2945956893A5068976678 @default.
• W2945956893 hasAuthorship W2945956893A5074081266 @default.
• W2945956893 hasAuthorship W2945956893A5080448752 @default.
• W2945956893 hasConcept C121608353 @default.
• W2945956893 hasConcept C126322002 @default.
• W2945956893 hasConcept C126894567 @default.
• W2945956893 hasConcept C142724271 @default.
• W2945956893 hasConcept C204787440 @default.
• W2945956893 hasConcept C27081682 @default.
• W2945956893 hasConcept C2775874879 @default.
• W2945956893 hasConcept C2776235491 @default.
• W2945956893 hasConcept C2777562237 @default.
• W2945956893 hasConcept C2779466945 @default.
• W2945956893 hasConcept C2779478474 @default.
• W2945956893 hasConcept C2780542891 @default.
• W2945956893 hasConcept C2780768273 @default.
• W2945956893 hasConcept C2910366748 @default.
• W2945956893 hasConcept C71924100 @default.
• W2945956893 hasConceptScore W2945956893C121608353 @default.
• W2945956893 hasConceptScore W2945956893C126322002 @default.
• W2945956893 hasConceptScore W2945956893C126894567 @default.
• W2945956893 hasConceptScore W2945956893C142724271 @default.
• W2945956893 hasConceptScore W2945956893C204787440 @default.
• W2945956893 hasConceptScore W2945956893C27081682 @default.
• W2945956893 hasConceptScore W2945956893C2775874879 @default.
• W2945956893 hasConceptScore W2945956893C2776235491 @default.
• W2945956893 hasConceptScore W2945956893C2777562237 @default.
• W2945956893 hasConceptScore W2945956893C2779466945 @default.
• W2945956893 hasConceptScore W2945956893C2779478474 @default.
• W2945956893 hasConceptScore W2945956893C2780542891 @default.
• W2945956893 hasConceptScore W2945956893C2780768273 @default.
• W2945956893 hasConceptScore W2945956893C2910366748 @default.
• W2945956893 hasConceptScore W2945956893C71924100 @default.
• W2945956893 hasFunder F4320310856 @default.
• W2945956893 hasFunder F4320312153 @default.
• W2945956893 hasFunder F4320313712 @default.
• W2945956893 hasFunder F4320319966 @default.
• W2945956893 hasFunder F4320322601 @default.
• W2945956893 hasFunder F4320335298 @default.
• W2945956893 hasLocation W29459568931 @default.
• W2945956893 hasLocation W29459568932 @default.
• W2945956893 hasOpenAccess W2945956893 @default.
• W2945956893 hasPrimaryLocation W29459568931 @default.
• W2945956893 hasRelatedWork W2102736746 @default.
• W2945956893 hasRelatedWork W2891624978 @default.
• W2945956893 hasRelatedWork W2999139057 @default.
• W2945956893 hasRelatedWork W4205328221 @default.
• W2945956893 hasRelatedWork W4220807700 @default.
• W2945956893 hasRelatedWork W4231649126 @default.
• W2945956893 hasRelatedWork W4238320935 @default.

• next